The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Open accessAbstract
Background: Paraneoplastic neurological syndromes (PNS) almost invariably predate detection of the malignancy. Screening for tumours is important in PNS as the tumour directly affects prognosis and treatment and should be performed as soon as possible. Objectives: An overview of the screening of tumours related to classical PNS is given. Small cell lung cancer, thymoma, breast cancer, ovarian carcinoma and teratoma and testicular tumours are described in relation to paraneoplastic limbic encephalitis, subacute sensory neuronopathy, subacute autonomic neuropathy, paraneoplastic cerebellar degeneration, paraneoplastic opsoclonus‐myoclonus, Lambert‐Eaton myasthenic syndrome (LEMS), myasthenia gravis and paraneoplastic peripheral nerve hyperexcitability. Methods: Many studies with class IV evidence were available; one study reached level III evidence. No evidence‐based recommendations grade A–C were possible, but good practice points were agreed by consensus. Recommendations: The nature of antibody, and to a lesser extent the clinical syndrome, determines the risk and type of an underlying malignancy. For screening of the thoracic region, a CT‐thorax is recommended, which if negative is followed by fluorodeoxyglucose‐positron emission tomography (FDG‐PET). Breast cancer is screened for by mammography, followed by MRI. For the pelvic region, ultrasound (US) is the investigation of first choice followed by CT. Dermatomyositis patients should have CT‐thorax/abdomen, US of the pelvic region and mammography in women, US of testes in men under 50 years and colonoscopy in men and women over 50. If primary screening is negative, repeat screening after 3–6 months and screen every 6 months up till 4 years. In LEMS, screening for 2 years is sufficient. In syndromes where only a subgroup of patients have a malignancy, tumour markers have additional value to predict a probable malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Self-citationAmerican Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Recommended diagnostic criteria for paraneoplastic neurological syndromes
Graus, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.034447 · Cited by 1,610
Self-citationLai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Self-citationIrani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,123
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M. B., Grisold, W., Kimura, A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70324-2 · Cited by 928
Self-citationAnti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Self-citationParaneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Self-citationDalmau, J., Graus, F., Rosenblum, M. K., & Posner, J. B. (1992) · MEDICINE · doi:10.1097/00005792-199203000-00001 · Cited by 819
Self-citationAMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Lai, M., Hughes, E. G., Peng, X., Zhou, L., Gleichman, A. J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M. D., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21589 · Cited by 813
Self-citationClinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 771
Self-citationTHE LAMBERT-EATON MYASTHENIC SYNDROME: A REVIEW OF 50 CASES
O'NEILL, J. H., MURRAY, N. M. F., & NEWSOM-DAVIS, J. (1988) · Brain · doi:10.1093/brain/111.3.577 · Cited by 686
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Self-citationMD, K. P., Rosenblum, M. K., MS, H. K., & Posner, J. B. (1992) · Neurology · doi:10.1212/wnl.42.10.1931 · Cited by 608
Shams’ili, S., Grefkens, J., de Leeuw, B., van den Bent, M., Hooijkaas, H., van der Holt, B., Vecht, C., & Sillevis Smitt, P. (2003) · Brain · doi:10.1093/brain/awg133 · Cited by 579
Self-citationMotzer, R. J., Agarwal, N., Beard, C., Bolger, G. B., Boston, B., Carducci, M. A., Choueiri, T. K., Figlin, R. A., Fishman, M., Hancock, S. L., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0043 · Cited by 470
Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor
Smitt, P. S., Kinoshita, A., De Leeuw, B., Moll, W., Coesmans, M., Jaarsma, D., Henzen-Logmans, S., Vecht, C., De Zeeuw, C., Sekiyama, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420104 · Cited by 451
Phenotypic variants of autoimmune peripheral nerve hyperexcitability
Hart, I. K. (2002) · Brain · doi:10.1093/brain/awf178 · Cited by 427
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
Luque, F. A., Furneaux, H. M., Ferziger, R., Rosenblum, M. K., Wray, S. H., Schold, S. C., Glantz, M. J., Jaeckle, K. A., Biran, H., Lesser, M., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290303 · Cited by 402
Clarke-Pearson, D. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0901926 · Cited by 400
Antibodies and neuronal autoimmune disorders of the CNS
Graus, F., Saiz, A., & Dalmau, J. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 392
Self-citationBrainin, M., Barnes, M., Baron, J. ‐., Gilhus, N. E., Hughes, R., Selmaj, K., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 375
Self-citationNeurologic Complications of Cancer
Wen, P. Y., & Glantz, M. J. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00100-7 · Cited by 361
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2003) · Annals of Neurology · doi:10.1002/ana.10518 · Cited by 331
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease
Bernal, F. J. A., Shamsili, S., Rojas-Marcos, I., Sánchez‐Valle, R., Saiz, A., Dalmau, J. O., Honnorat, J., Smitt, P. A. E. S., & Graus, F. (2003) · Neurology · doi:10.1212/01.wnl.0000041495.87539.98 · Cited by 329
Self-citationThe natural course of myasthenia gravis: a long term follow up study.
Oosterhuis, H. J. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.10.1121 · Cited by 326
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies
Rojas-Marcos, I., Graus, F., Keime-Guibert, F., Reñé, R., Delattre, J., Ramon, J. M., Dalmau, J. O., & Posner, J. B. (2000) · Neurology · doi:10.1212/wnl.55.5.713 · Cited by 323
Self-citationLeone, M. A., Brainin, M., Boon, P., Pugliatti, M., Keindl, M., & Bassetti, C. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12043 · Cited by 280
Honnorat, J., Cartalat-Carel, S., Ricard, D., Camdessanche, J. P., Carpentier, A. F., Rogemond, V, Chapuis, F., Aguera, M., Decullier, E., Duchemin, A. M., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.138016 · Cited by 272
Self-citationSkates, S. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.955 · Cited by 256
Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy
Adamus, G., Ren, G., & Weleber, R. G. (2004) · BMC Ophthalmology · doi:10.1186/1471-2415-4-5 · Cited by 254
Sillevis Smitt, P., Grefkens, J., de Leeuw, B., van den Bent, M., van Putten, W., Hooijkaas, H., & Vecht, C. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0706-4 · Cited by 249
Self-citationFDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes
Younes-Mhenni, S. (2004) · Brain · doi:10.1093/brain/awh247 · Cited by 237
Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma
Vernino, S., Tuite, P., Adler, C. H., Meschia, J. F., Boeve, B. F., Boasberg, P., Parisi, J. E., & Lennon, V. A. (2002) · Annals of Neurology · doi:10.1002/ana.10178 · Cited by 228
Vernino, S., Adamski, J., Kryzer, T. J., Fealey, R. D., & Lennon, V. A. (1998) · Neurology · doi:10.1212/wnl.50.6.1806 · Cited by 226
Mature and immature ovarian teratomas: CT, US and MR imaging characteristics
Saba, L., Guerriero, S., Sulcis, R., Virgilio, B. A., Melis, G. B., & Mallarini, G. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.07.044 · Cited by 224
Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened
van Nagell, J. R., DePriest, P. D., Ueland, F. R., DeSimone, C. P., Cooper, A. L., McDonald, J. M., Pavlik, E. J., & Kryscio, R. J. (2007) · Cancer · doi:10.1002/cncr.22594 · Cited by 217
Stiff-person syndrome with amphiphysin antibodies: Distinctive features of a rare disease
Murinson, B. B., & Guarnaccia, J. B. (2008) · Neurology · doi:10.1212/01.wnl.0000327342.58936.e0 · Cited by 213
Graus, F., Dalmau, J., Valldeoriola, F., Ferrer, I., Reñé, R., Marin, C., Vecht, C. J., Arbizu, T., Targa, C., & Moll, J. W. B. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00205-6 · Cited by 206
Self-citationTitulaer, M. J., Klooster, R., Potman, M., Sabater, L., Graus, F., Hegeman, I. M., Thijssen, P. E., Wirtz, P. W., Twijnstra, A., Smitt, P. A. E. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6169 · Cited by 206
Self-citationParaneoplastic Syndromes Affecting the Nervous System
Khasraw, M., & Khakoo, Y. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00101-3 · Cited by 204
Paraneoplastic cerebellar degeneration: A clinical and CT study
Greenberg, H. (1984) · Journal of Neuro-Oncology · doi:10.1007/bf00178121 · Cited by 204
Paraneoplastic Syndromes Affecting the Nervous System
Darnell, R. B., & Posner, J. B. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.008 · Cited by 177
Rees, J. H. (2001) · Brain · doi:10.1093/brain/124.11.2223 · Cited by 173
Antoine, J. C., Absi, L., Honnorat, J., Boulesteix, J.-M., de Brouker, T., Vial, C., Butler, M., De Camilli, P., & Michel, D. (1999) · Archives of Neurology · doi:10.1001/archneur.56.2.172 · Cited by 165
Self-citationANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity
Chan, K. H., Vernino, S., & Lennon, V. A. (2001) · Annals of Neurology · doi:10.1002/ana.1127 · Cited by 164
Antibody-positive paraneoplastic neurologic syndromes
Linke, R., Schroeder, M., Helmberger, T. K., & Voltz, R. (2004) · Neurology · doi:10.1212/01.wnl.0000129983.06983.4e · Cited by 141
Self-citationTitulaer, M. J., Wirtz, P. W., Willems, L., van Kralingen, K. W., Smitt, P. A. E. S., & Verschuuren, J. J. G. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5133 · Cited by 141
Self-citationPeripheral nervous system involvement in patients with cancer
Antoine, J.-C. G., & Camdessanché, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70679-2 · Cited by 134
Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis
Mathew, R. M., Vandenberghe, R. R., Garcı́a-Merino, A., Yamamoto, T., Landolfi, J. C., Rosenfeld, M. R., Rossi, J., Thiessen, B. A., Dropcho, E. J., & Dalmau, J. O. (2006) · Neurology · doi:10.1212/01.wnl.0000252379.81933.80 · Cited by 106
Self-citationClinical and immunologic aspects of cancer-associated retinopathy
Ohguro, H., Yokoi, Y., Ohguro, I., Mamiya, K., Ishikawa, F., Yamazaki, H., Metoki, T., Takano, Y., Ito, T., & Nakazawa, M. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.01.010 · Cited by 105
Treatment of Breast Cancer in Countries with Limited Resources
Carlson, R. W., Anderson, B. O., Chopra, R., Eniu, A. E., Jakesz, R., Love, R. R., Masetti, R., & Schwartsmann, G. (2003) · The Breast Journal · doi:10.1046/j.1524-4741.9.s2.6.x · Cited by 83
Liu, J., Xu, Y., & Wang, J. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.02.040 · Cited by 80
Guerriero, S., Mallarini, G., AJOSSA, S., Risalvato, A., Satta, R., Mais, V., Angiolucci, M., & Melis, G. B. (1997) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1997.09050339.x · Cited by 78
Vural, B., Chen, L., Saip, P. M., Chen, Y., Üstüner, Z., Gönen, M., Simpson, A. J. G., Old, L. J., Özbek, U., & Gure, A. O. (2005) · Cancer · doi:10.1002/cncr.21088 · Cited by 78
Liu, R. S., Yeh, S. H., Huang, M., Wang, L. S., Chu, L. S., Chang, C. P., Chu, Y. K., & Wu, L. C. (1995) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01791148 · Cited by 77
Onconeural antibodies in sera from patients with various types of tumours
Monstad, S. E., Knudsen, A., Salvesen, H. B., Aarseth, J. H., & Vedeler, C. A. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0690-y · Cited by 75
Self-citationLiesegang, T. J. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01034-0 · Cited by 68
Juvenile Dermatomyositis as a Paraneoplastic Phenomenon: An Update
Morris, P. W., & Dare, J. A. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181bf29a2 · Cited by 67
Relation between dermatomyositis and polymyositis and cancer
Callen, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03535-2 · Cited by 65
Hadjivassiliou, M., Alder, S., van Beek, E. J. R., Hanney, M. B., Lorenz, E., Rao, D. G., Sharrack, B., & Tindale, W. B. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01089.x · Cited by 60
Sahashi, K. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1332 · Cited by 52
Autoimmune and paraneoplastic channelopathies
Vernino, S. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.01.007 · Cited by 46
Update on paraneoplastic neurological syndromes
Didelot, A., & Honnorat, J. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283306647 · Cited by 40
Self-citationBrainin, M., Barnes, M., Baron, J., Ne, G., Hughes, R. A., Selmaj, K. W., & Waldemar, G. (2011) · Wiley eBooks · doi:10.1002/9781444346268.ch1 · Cited by 38
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Self-citationChemotherapy‐induced peripheral neurotoxicity: A critical analysis
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21204 · Cited by 741
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Self-citationAutoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
Abboud, H., Probasco, J. C., Irani, S., Ances, B., Benavides, D. R., Bradshaw, M., Christo, P. P., Dale, R. C., Fernandez-Fournier, M., Flanagan, E. P., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325300 · Cited by 554
Self-citationLambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies
Titulaer, M. J., Lang, B., & Verschuuren, J. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70245-9 · Cited by 408
Self-citation
Metadata
- Authors
- Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., Vedeler, C. A., Voltz, R., & Verschuuren, J. J. G. M.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2010-09-29
- Volume
- 18
- Issue
- 1
- Pages
- 19
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2134741840
- Cited by
- 526
- References
- 72
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.